顶刊论文（社媒热度）精选评分53
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
No English body on site. Use the original article link above.
No English body on site. Use the original article link above.